Next generation immuno-oncology tumor profiling using a rapid, non-invasive, computational biophysics biomarker in early-stage breast cancer

BACKGROUND: Immuno-oncology (IO) therapies targeting the PD-1/PD-L1 axis, such as immune checkpoint inhibitor (ICI) antibodies, have emerged as promising treatments for early-stage breast cancer (ESBC). Despite immunotherapy's clinical significance, the number of benefiting patients remains sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Daniel, Biancalana, Matthew, Liadis, Nicole, Lopez Ramos, Dorys, Zhang, Yuhan, Patel, Snehal, Peterson, Joseph R., Pfeiffer, John R., Cole, John A., Antony, Anuja K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Artificial Intelligence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149754/
https://www.ncbi.nlm.nih.gov/pubmed/37138891
http://dx.doi.org/10.3389/frai.2023.1153083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149754/
https://www.ncbi.nlm.nih.gov/pubmed/37138891
http://dx.doi.org/10.3389/frai.2023.1153083

Ejemplares similares